EDIT
Editas Medicine Inc
NASDAQ: EDIT · HEALTHCARE · BIOTECHNOLOGY
$2.82
-7.84% today
Updated 2026-04-29
Market cap
$284.81M
P/E ratio
—
P/S ratio
7.03x
EPS (TTM)
$-1.80
Dividend yield
—
52W range
$1 – $5
Volume
1.7M
Editas Medicine Inc (EDIT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-56.70%
ROE
-198.10%
ROA
-23.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2013 | — | $-5.35M | — | — | — |
| 2014 | $0.00 | $-13.69M | — | — | — |
| 2015 | $1.63M | $-72.90M | -1,056.91% | -2,167.71% | -4,475.14% |
| 2016 | $6.05M | $-97.18M | -841.33% | -1,605.62% | -1,605.53% |
| 2017 | $13.73M | $-120.32M | -505.76% | -873.64% | -876.49% |
| 2018 | $31.94M | $-109.95M | -183.85% | -356.10% | -344.28% |
| 2019 | $20.53M | $-133.75M | -371.96% | -686.39% | -651.43% |
| 2020 | $90.73M | $-109.41M | 100.00% | -148.61% | -120.59% |
| 2021 | $25.54M | $-185.11M | 100.00% | -756.13% | -724.66% |
| 2022 | $19.71M | $-204.35M | 100.00% | -1,146.26% | -1,036.69% |
| 2023 | $78.12M | $-153.22M | 92.24% | -216.56% | -196.13% |
| 2024 | $32.31M | $-237.09M | 100.00% | -777.22% | -733.72% |
| 2025 | $40.52M | $-160.06M | 100.00% | -245.15% | -395.01% |